Clinical Trial Update: BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial comparing Busulfan-Cyclophosphamide (BuCy) versus Total Body Irradiation-Cyclophosphamide (TBICy) conditioning for allogeneic h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: T-Cell Lymphocytic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION | Phase 3 | Status: NOT_YET_RECRUITING